Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-01-12
DOI
10.1038/s41598-018-35367-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency
- (2016) Silje F Jørgensen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Gut Microbiome Associates With Lifetime Cardiovascular Disease Risk Profile Among Bogalusa Heart Study ParticipantsNovelty and Significance
- (2016) Tanika N. Kelly et al. CIRCULATION RESEARCH
- Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior
- (2016) Pauline Luczynski et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation
- (2016) S F Jørgensen et al. Mucosal Immunology
- Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
- (2015) Venkatanarayana Gangarapu et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis
- (2015) D. Kevans et al. Journal of Crohns & Colitis
- Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study
- (2015) Xin Zeng et al. Journal of Digestive Diseases
- Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia
- (2015) Georgios N. Kalambokis et al. LIVER INTERNATIONAL
- Rifaximin: beyond the traditional antibiotic activity
- (2014) Fiorella Calanni et al. JOURNAL OF ANTIBIOTICS
- Rifaximin has a Marginal Impact on Microbial Translocation, T-cell Activation and Inflammation in HIV-Positive Immune Non-responders to Antiretroviral Therapy – ACTG A5286
- (2014) Allan R. Tenorio et al. JOURNAL OF INFECTIOUS DISEASES
- Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
- (2014) J F Vázquez-Castellanos et al. Mucosal Immunology
- Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency
- (2014) Waleed Al-Herz et al. Frontiers in Immunology
- Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform
- (2013) James J. Kozich et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
- (2013) Genta Kakiyama et al. JOURNAL OF HEPATOLOGY
- Rifaximin for Preventing Acute Graft-Versus-Host Disease
- (2013) Muna Qayed et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
- (2013) Jasmohan S. Bajaj et al. PLoS One
- Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags
- (2010) Gary D Wu et al. BMC MICROBIOLOGY
- Toward defining the autoimmune microbiome for type 1 diabetes
- (2010) Adriana Giongo et al. ISME Journal
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Rifaximin Treatment in Hepatic Encephalopathy
- (2010) Nathan M. Bass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
- (2010) Y. K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of B cells in common variable immune deficiency
- (2009) Sam Ahn et al. Expert Review of Clinical Immunology
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
- (2009) P. D. Cani et al. GUT
- Common variable immunodeficiency disorders: division into distinct clinical phenotypes
- (2008) H. Chapel et al. BLOOD
- A core gut microbiome in obese and lean twins
- (2008) Peter J. Turnbaugh et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now